Short-Term Bixin Supplementation of Healthy Subjects Decreases the Susceptibility of LDL to Cu2+-Induced Oxidation Ex Vivo
Table 1
Baseline characteristics of 16 volunteers enrolled in the randomized, controlled clinical trial.
Parameters
Population ()
Reference values
Age (years)
25.4 ± 0.8
—
Weight (kg)
66.5 ± 2.2
—
Height (m)
1.71 ± 0.03
—
Sex
8 males/8 females
—
Waist circumference (cm)
80.9 ± 2.1
Men < 94.0
Women < 80.0
Systolic blood pressure (mmHg)
110 ± 0.5
<120
Diastolic blood pressure (mmHg)
80 ± 0.4
<80
Body mass index (kg/cm2)
22.6 ± 0.7
18.5–24.9
ALT (U/L)
19.0 ± 2.0
<45.0
AST (U/L)
18.7 ± 1.6
<35.0
TC (mg/dL)
179.6 ± 6.9
<190.0
HDL-C (mg/dL)
52.0 ± 4.3
>40.0
LDL-C (mg/dL)
110.1 ± 4.9
<130.0
TG (mg/dL)
87.4 ± 12.4
<150.0
Glucose (mg/dL)
92.5 ± 2.4
60.0–100.0
Creatinine (mg/dL)
1.15 ± 0.06
0.4–1.4
Urea (mg/dL)
28.7 ± 1.7
10–50.0
Values are expressed as mean ± SEM. ALT, alanine aminotransferase; AST, aspartate aminotransferase; TC, total cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglycerides.
